Retired Forms Manuals |
---|
Form Number | Form Name | Form Version |
Retired Date |
---|
2000
| Baseline Form Instructions (PDF)
| 5.0
| October 2020
|
2000 | Baseline Form Instructions (PDF) | 4.0 | January 2020 |
2000 | Baseline Form Instructions (PDF) | 4.0 | March 2015 |
2000 |
Baseline Form Instructions (PDF) | 3.0 | October 2013 |
2004 | Infectious Disease Markers Form Instructions (PDF) | 4.0 | January 2020 |
2004 | Infectious Disease Markers Form Instructions (PDF) | 4.0 | March 2015 |
2004 | Infectious Disease Markers Form Instructions (PDF) | 3.0 | October 2013 |
2005 | Confirmation of HLA Typing Form Instructions (PDF) | 6.0 | January 2020 |
2005 | Confirmation of HLA Typing Form Instructions (PDF) | 5.0 | January 2017 |
2005 | Confirmation of HLA Typing Form Instructions (PDF) | 4.0 | October 2013 |
2006 | Infusion Form Instructions (PDF) | 4.0 | January 2020 |
2006 | Infusion Form Instructions (PDF) | 4.0 | March 2015 |
2006 | Infusion Form Instructions (PDF) | 2.0 | October 2013 |
2006 |
Infusion Form FAQ (PDF) | 1.0 | February 2010 |
2010 | Acute Myelogenous Leukemia (AML) Pre-HCT Data Form Instructions (PDF) | 3.0 | July 2017 |
2010 | Acute Myelogenous Leukemia (AML) Pre-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2011 | Acute Lymphoblastic Leukemia (ALL) Pre-HCT Data Form Instructions (PDF) | 4.0 | July 2017 |
2013 | Chronic Lymphocytic Leukemia (CLL) Pre-HCT Data Form Instructions (PDF) | 2.0 | March 2015 |
2014 | Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Pre-HCT Data Form Instructions (PDF) | 3.0 | May 2020 |
2014 | Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Pre-HCT Data Form Instructions (PDF) | 2.0 | March 2015 |
2015
| Juvenile Myelomonocytic Leukemia (JMML) Pre-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2016
| Multiple Myleoma / Plasma Cell Disorders (PCD) Pre-HCT Data Form Instructions (PDF)
| 3.0
| April 2021
|
2016 |
Multiple Myleoma / Plasma Cell Disorders (PCD) Pre-HCT Data Form Instructions (PDF) | 3.0 | January 2020 |
2016 |
Multiple Myeloma / Plasma Cell Disorders (PCD) Pre-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2016 | Multiple Myeloma / Plasma Cell Leukemia Pre-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2018 | Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form Instructions (PDF) | 4.0 | January 2019 |
2018
| Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form Instructions (PDF)
| 5.0
| October 2020
|
2018
|
Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form Instructions (PDF) | 3.0 | January 2018 |
2018 | Hodgkin and Non-Hodgkin Lymphoma Pre-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2019 | Waldenstrom's Macroglobulinemia / Lymphoplasmacytic Lymphoma (MAC) Pre-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2028
| Aplastic Anemia Pre-HCT Data Form Instructions (PDF)
| 2.0
| October 2020
|
2028
| Aplastic Anemia Pre-HCT Data Form Instructions (PDF)
| 1.0 | March 2015 |
2034 |
X-Linked Lymphoproliferative Syndrome (XLP) Pre-HCT Data Form Instructions | 3.0 | March 2015 |
2039 | Hemophagocytic Lymphohistiocytosis (HLH) Pre-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2046 | Fungal Infection Pre-Infusion Data (PDF) | 4.0 | May 2018 |
2100
| Post-HCT Follow-Up (PDF)
| 6.0
| July 2021
|
2100
| 100 Day Post-HCT Data Form Instructions (PDF)
| 5.0
| October 2020
|
2100
| 100 Day Post-HCT Data Form Instructions (PDF) | 4.0 | July 2018 |
2100 | 100 Days Post-HCT Data Form Instructions (PDF) | 3.0 | January 2017 |
2110 | Acute Myelogeneous Leukemia (AML) Post-HCT Data Form Instructions (PDF) | 3.0 | July 2017 |
2110 | Acute Myelogenous Leukemia (AML) Post-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2111 | Acute Lymphoblastic Leukemia (ALL) Post-HCT Data Form Instructions (PDF) | 3.0 | July 2017 |
2113 | Chronic Lymphocytic Leukemia (CLL) Post-HCT Data Form Instructions (PDF) | 2.0 | March 2015 |
2114 | Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data Form Instructions (PDF) | 3.0 | May 2020 |
2114 | Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data Form Instructions (PDF) | 2.0 | March 2015 |
2115 |
Juvenile Myelomonocytic Leukemia (JMML) Post-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2116
| Multiple Myeloma / Plasma Cell Disorders (PCD) Post-HCT Data Form Instructions (PDF)
| 3.0
| April 2021
|
2116 | Multiple Myeloma / Plasma Cell Disorders (PCD) Post-HCT Data Form Instructions (PDF) | 3.0 | January 2020 |
2116
|
Multiple Myeloma / Plasma Cell Disorders (PCD) Post-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2116 | Multiple Myeloma / Plasma Cell Leukemia Post-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2118 |
Hodgkin and Non-Hodgkin Lymphoma Post-HCT Data Form Instructions (PDF) | 3.0 | January 2018 |
2118 | Hodgkin and Non-Hodgkin Lymphoma Post-HSCT Data Form Instructions (PDF) | 2.0 | October 2013 |
2119 | Waldenstrom's Macroglobulinemia / Lymphoplasmacytic Lymphoma (MAC) Post-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2128
| Aplastic Anemia Post-HCT Data Form Instructions (PDF)
| 2.0
| October 2020
|
2128
|
Aplastic Anemia Post-HCT Data Form Instructions (PDF) | 1.0 | March 2015 |
2134 |
X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2139 |
Hemophagocytic Lymphohistiocytosis (HLH) Post-HCT Data Form Instructions (PDF) | 3.0 | March 2015 |
2146 | Fungal Infection Post-Infusion Data (PDF) | 3.0 | May 2018 |
2200 |
Six Months to Two Years Post-HCT Data Form Instructions (PDF) | 3.0 | January 2017 |
2300 | Greater Than Two Years Post-HCT Data Form Instructions (PDF) | 3.0 | January 2017 |
2400
| Pre-TED Form Instructions (PDF) | 8.0
| October 2021
|
2400
| Pre-TED Form Instructions (PDF)
| 7.0
| January 2021
|
2400 | Pre-TED Form Instructions (PDF) | 6.0 | May 2020 |
2400 | Pre-TED Form Instructions (PDF) | 5.0 | January 2020 |
2400 | Pre-TED Form Instructions (PDF) | 4.0 | January 2017 |
2400 | Pre-TED Form Instructions (PDF) | 3.0 | October 2013 |
2402
| Pre-TED Disease Classification Form Instructions (PDF)
| 5.0
| October 2020
|
2402 | Pre-TED Disease Classification Form Instructions (PDF) | 4.0 | May 2020 |
2402 | Post-TED Disease Classification Form Instructions (PDF) | 3.0 | January 2020 |
2402 |
Pre-TED Disease Classification Form Instructions (PDF) | 2.0 | January 2018 |
2402 | Pre-TED Disease Classification Form Instructions (PDF) | 1.0 | July 2017 |
2450
| Post-TED Form Instructions (PDF) | 5.0
| October 2021 |
2450 | Post-TED Form Instructions (PDF) | 4.0 | January 2020 |
2450 | Post-TED Form Instructions (PDF) | 3.0 | January 2017 |
2540
| Tepadina® Supplemental Data Collection Form Instructions (PDF)
| 1.0
| April 2019
|
2556 |
Myelofibrosis Pre-HCT Data | 1.0 | May 2020 |
2557 | Myelofibrosis Post-HCT Data | 1.0 | May 2020 |
2800 | Log of Appended Documents Form Instructions (PDF) | 2.0 | March 2015 |
General Instructions Section 11 | Log of Appended Documents | N/A | August 2014 |
2804 | CIBMTR Recipient ID Assignment Form Instructions (PDF) | 5.0 | October 2019 |
2804 | CIBMTR Recipient ID Assignment Form Instructions (PDF) | 4.0 | March 2015 |
2814
| Indication Form Instructions (PDF)
| 2.0
| April 2019
|
2900
| Recipient Death Data Form Instructions (PDF) | 4.0
| October 2021
|
2900
| Recipient Death Data Form Instructions (PDF) | 3.0 | January 2019 |
2900 | Recipient Death Data Form Instructions (PDF) | 2.0 | January 2017 |
2900
|
Recipient Death Data Form Instructions (PDF) | 1.0 | March 2015 |
3500
| Subsequent Neoplasms (PDF)
| 1.0
| July 2021
|
4000
| Cellular Therapy Essential Data Pre-Infusion Form Instructions (PDF)
| 7.0
| July 2021
|
4000
| Cellular Therapy Essential Data Pre-Infusion Form Instructions (PDF)
| 6.0
| January 2021
|
4000 |
Cellular Therapy Essential Data Pre-Infusion Form Instructions (PDF) | 5.0 | January 2020 |
4000
|
Cellular Therapy Essential Data Pre-Infusion Form Instructions (PDF) | 4.0 | January 2018 |
4000
| Cellular Therapy Essential Data Pre-Infusion Form Instructions (PDF) | 3.0 | July 2017 |
4003
| Cellular Therapy Product Form Instructions (PDF)
| 4.0
| February 2022 |
4003
| Cellular Therapy Product Form Instructions (PDF)
| 3.0
| January 2021
|
4003 | Cellular Therapy Product Form Instructions (PDF) | 2.0 | January 2020 |
4003 | Cellular Therapy Product Form Instructions (PDF) | 1.0 | January 2019 |
4006
| Cellular Therapy Infusion Data Form Instructions (PDF) | 5.0
| February 2022
|
4006
| Cellular Therapy Infusion Data Form Instructions (PDF)
| 4.0
| January 2021
|
4006 | Cellular Therapy Infusion Data Form Instructions (PDF) | 3.0 | January 2020 |
4006 |
Cellular Therapy Infusion Data Form Instructions (PDF) | 2.0 | January 2018 |
4006 | Cellular Therapy Infusion Data Form Instructions (PDF) | 1.0 | July 2017 |
4100
| Cellular Therapy Essential Data Follow-Up Form Instructions (PDF) | 7.0
| February 2022
|
4100
| Cellular Therapy Essential Data Follow-Up Form Instructions (PDF)
| 6.0
| July 2021
|
4100
| Cellular Therapy Essential Data Follow-Up Form Instructions (PDF)
| 5.0
| January 2021
|
4100 | Cellular Therapy Essential Data Follow-Up Form Instructions (PDF) | 4.0 | January 2020 |
4100 | Cellular Therapy Essential Data Follow-Up Form Instructions (PDF) | 3.0 | October 2018 |
4100 |
Cellular Therapy Essential Data Follow-Up Form Instructions (PDF) | 2.0 | January 2018 |
4100 | Cellular Therapy Essential Data Follow-Up Form Instructions (PDF) | 1.0 | July 2017 |
N/A |
Supplemental Report Form Manuals | N/A | September 2013 |
N/A |
TED Manual (PDF) | N/A | January 2008 |
N/A |
NMDP Forms Instruction Manual (PDF) | N/A | December 2007 |
N/A
| CIBMTR Data Management Manual (PDF)
| N/A
| December 2007
|
N/A
| CIBMTR Registration Instruction Manual (PDF)
| N/A
| December 2007
|